Quick Summary
Covering the latest research from top Wall Street investment banks

UBS sees Burberry's transformation path becoming clearer, and management remains confident in FY27 and beyond

Institution
UBS
Date
2026-05-18
Authors
Zuzanna Pusz, CFA, Chris Huang, CFA, Robert Krankowski
Company
Burberry
Ticker
BRBY.L
Industry
Clothing & Fabrics
Rating
Buy
BullishLow confidenceIn the conference call, management expressed confidence in FY27 and the medium-term sales path, emphasizing improvements driven by marketing initiatives, the transformation progress, conversion rates, and category expansion, while UBS maintained its Buy rating and a target price above the current share price.
AuthorsZuzanna Pusz, CFA, Chris Huang, CFA, Robert Krankowski
Target priceGBp1,410
CoverageEurope、Other
Asset classesEquity
Business segmentsapparel、outerwear、leather goods、accessories、retail、wholesale、licensing
Research firm divisions/subsidiariesUBS Europe SE(Other)、UBS AG(Other)

AI summary card

UBS sees Burberry's transformation path becoming clearer, and management remains confident in FY27 and beyond

Burberry's conference-call feedback was positive: management stressed that the marketing campaign is still early, conversion is strong, gross margin is improving, and cost discipline is supporting the recovery. UBS maintains a Buy rating and a GBp1,410 target price.

12-month rating is Buy; target price GBp1,410, disclosed current price 1,163p, implied upside 27.4%, forecast dividend yield 0.0%, and forecast total return 27.4%.
BurberryBRBY.LBuy RatingLuxury GoodsTransformation RecoveryGross Margin ImprovementDCF and Relative Valuation
  • Management said that after entering the next stage of the transformation, current momentum is expected to continue through 2027 and beyond, while the company keeps moving toward its medium-term sales target of about £3bn.
  • FY26 gross margin expansion reached 540bp, above the original 300-350bp target, driven mainly by lower markdowns and a higher full-price sell-through rate.
  • The company emphasized that Burberry is a year-round brand, with trench coats also selling well in summer, and that summer categories such as swimwear are performing well, helping to ease concerns over seasonality.
  • On valuation, the report says BRBY trades at 1.9x and 1.8x 2026e and 2027e EV/Sales, respectively, and that 2026e-2029e sales and EPS CAGR are +5% and +38%, respectively.

Report interpretation

Overview

This report is UBS's company-research feedback after Burberry's conference call. The core conclusion is that management's tone is positive and it remains confident in the transformation progress, the continuation of FY27 momentum, and the medium-term sales path of about £3bn. The report focuses on marketing initiatives, product categories, gross margin, cost control, seasonality concerns, valuation, and risks.

Core views

UBS believes Burberry's recovery base is improving: the marketing campaign is still in its early stages but is having a strong impact; despite weak store traffic across the industry, the company is still seeing very strong conversion rates; its year-round product mix has broad global appeal; FY26 AUR declined in the low single digits but stabilized during the year, and is expected to stop being a drag in FY27; and advantages in accessories are starting to extend into other categories, with early signs of improvement in leather goods. Gross margin improvement has exceeded expectations, and the path toward the roughly 70% gross margin target may be more gradual, while FY27 still has about £20m of cost cuts to be delivered, with OPEX discipline used to offset cost inflation.

Analysis framework

The report combines management comments from the conference call, FY26 operating metrics, FY27 outlook, product and channel feedback, financial forecasts, and DCF and relative valuation methods to support the Buy rating and target price. The analysis focuses on whether transformation momentum is sustainable, the path to gross margin and EBIT margin recovery, whether seasonality risks are overstated, and how valuation aligns with earnings recovery.

Methodology notes

  • Valuation methodsDCF and relative multiples valuation

    The target price is supported by both DCF and relative valuation

    The report explicitly states that Burberry's target price is based on DCF and relative multiple valuation methods, and it assesses valuation attractiveness using forecast metrics such as EV/Sales, margins, EPS, and cash flow.

  • rating frameworkForecast Stock Return and Market Return Assumption

    Comparison of 12-month expected return with the market return assumption

    UBS defines Forecast Stock Return as the expected share-price appreciation over the next 12 months plus dividend yield, and Market Return Assumption as the one-year local market rate plus 5%; Buy usually corresponds to FSR being significantly above MRA.

  • operating analysisTransformation recovery tracking

    Sales momentum, gross margin, cost cuts, and category expansion

    The report assesses transformation quality through the effectiveness of marketing activity, conversion rates, AUR, gross margin, full-price sales, cost cuts, and the extension of accessories into leather goods and other categories.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Burberry equity (BRBY.L)
    research target
    Strengths
    A global British luxury brand with strong recognition in core outerwear and apparel; retail accounts for more than 80% of sales; management emphasizes high conversion, year-round products, and continued transformation momentum; gross margin improvement has exceeded expectations.
    Weaknesses
    FY25 earnings are at a low point, FY26 revenue remains below FY23 levels; dividends are zero during the 03/25 to 03/28E forecast period; outlet channels, especially in EMEA, continue to face traffic pressure.
    Comparison
    At 1.9x and 1.8x 2026e and 2027e EV/Sales, respectively, the report expects 2026e-2029e sales CAGR of +5% and EPS CAGR of +38%, indicating greater earnings-recovery leverage than sales growth.
    Risks
    External consumer shocks, political changes, pricing pressure, brand-value volatility, management execution and succession, shifts in market perception of long-term growth, and FX volatility.

Key data

  • 12-month ratingBuyThe chart disclosure shows Burberry's 12-month rating as Buy.
  • Target priceGBp1,410The valuation section discloses a Buy rating and a GBp1,410 target price, based on DCF and relative multiples.
  • Disclosed current price1,163pThe company disclosure table shows the price date as 2026-05-13.
  • Forecast share-price upside27.4%The forecast return chart shows forecast price appreciation of 27.4%.
  • Forecast dividend yield0.0%The forecast return chart shows forecast dividend yield of 0.0%.
  • Forecast total return27.4%The forecast return chart shows forecast stock return of 27.4%.
  • Market return assumption9.3%The forecast return chart shows the market return assumption at 9.3%.
  • Forecast excess return18.1%The forecast return chart shows forecast excess return of 18.1%.
  • FY26 gross margin expansion+540bp y/yAbove the original 300-350bp target, driven mainly by lower markdowns and a higher full-price sell-through rate.
  • Remaining FY27 cost cutsabout £20mManagement said that about £20m of the cost-cutting plan is still to be delivered in FY27.
  • 2026e/2027e EV/Sales1.9x / 1.8xThe report says BRBY trades at 1.9x and 1.8x 2026e and 2027e EV/Sales, respectively.
  • 2026e-2029e three-year sales CAGR+5%The report discloses the forecast three-year sales CAGR.
  • 2026e-2029e three-year EPS CAGR+38%The report discloses the forecast three-year EPS CAGR.
  • 03/26E market snapshotMarket cap £3.97b / US$5.36b, 52-week range 1,372p-962pDisclosed in the trading data chart.

Impact & implications

For investors, the main takeaway from the report is that Burberry's transformation is entering a more verifiable phase: if marketing investment, full-price sales, category expansion, and cost cuts continue to deliver, earnings recovery should support valuation normalization; however, weak luxury-sector traffic, channel performance, brand execution, and the external consumer environment may still affect the pace of recovery.

Risks

  • Industry traffic remains challenging, especially in outlet channels and EMEA.
  • Transformation execution risk, including brand positioning, product cadence, management execution, and succession issues.
  • External consumer shock risks, including the impact of terrorism and pandemics on luxury spending.
  • Severe political changes and sanctions, as well as other macro or regulatory events, could affect demand and distribution.
  • Pricing pressure may affect AUR, full-price sales, and gross margin recovery.
  • Damage to brand value or changes in the market's long-term growth expectations for the company may weigh on valuation.
  • FX volatility may affect the value, price, or income of the securities.
  • Valuation depends on multiple assumptions, and changes in DCF or multiple assumptions may materially alter the target price and investment conclusion.

What to watch

  • Whether FY27 sales momentum continues, especially the effect of marketing initiatives as they move from the early stage to broader conversion.
  • Whether AUR truly stops being a drag in FY27.
  • The pace of progress toward the roughly 70% gross margin target, and whether there is additional upside from high-quality sales.
  • Whether the roughly £20m of FY27 cost cuts are delivered on schedule, and whether OPEX discipline can offset cost inflation.
  • Whether the strength in accessories can continue to extend into leather goods and other categories.
  • Whether outlet-channel and EMEA traffic stabilize.
  • Whether same-store sales growth slows because of seasonality concerns or industry traffic pressure.
  • Whether the market continues to assign the upside implied by the Buy rating, including earnings recovery and valuation normalization.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins